2009
DOI: 10.1016/j.jphotobiol.2009.08.004
|View full text |Cite
|
Sign up to set email alerts
|

Studies on curcumin and curcuminoids. XXXIV. Photophysical properties of a symmetrical, non-substituted curcumin analogue

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

13
91
0

Year Published

2010
2010
2018
2018

Publication Types

Select...
4
2
1

Relationship

1
6

Authors

Journals

citations
Cited by 60 publications
(104 citation statements)
references
References 58 publications
13
91
0
Order By: Relevance
“…The tendency of the keto↔enol equilibrium to shift toward the enol tautomer in these solvent systems has been confirmed experimentally by Fourier transform infrared spectroscopy (FT-IR) (Kolev et al, 2005), nuclear magnetic resonance spectroscopy (NMR) (Roughley and Whiting, 1973;Unterhalt, 1980;Gorman et al, 1994;Khopde et al, 2000), fluorescence spectroscopy (Khopde et al, 2000;Nardo et al, 2008), and absorption spectroscopy (Khopde et al, 2000;Nardo et al, 2008) as well as computationally (Kolev et al, 2005;Balasubramanian, 2006;Payton et al, 2007;Galano et al, 2009). In nonpolar solvents, the steadystate absorption spectra of curcumin in cyclohexane (Nardo et al, 2008), toluene , benzene (Khopde et al, 2000), and others (Tønnesen et al, 1995) exhibit a concrete red band or shoulder, which has been ascribed to the diketo tautomer (Khopde et al, 2000;Nardo et al, 2008Nardo et al, , 2009. Curcumin hence adopts both the enol and diketo tautomeric form in nonpolar environments (Balasubramanian, 2006), albeit the diketo tautomer is quantitatively exiguous relative to the enol tautomer (Kolev et al, 2005), and exclusively the enol tautomeric form in solvents with increasing « r (Fig.…”
Section: A Curcumin Structure: Implications On Intermolecular Interamentioning
confidence: 88%
See 3 more Smart Citations
“…The tendency of the keto↔enol equilibrium to shift toward the enol tautomer in these solvent systems has been confirmed experimentally by Fourier transform infrared spectroscopy (FT-IR) (Kolev et al, 2005), nuclear magnetic resonance spectroscopy (NMR) (Roughley and Whiting, 1973;Unterhalt, 1980;Gorman et al, 1994;Khopde et al, 2000), fluorescence spectroscopy (Khopde et al, 2000;Nardo et al, 2008), and absorption spectroscopy (Khopde et al, 2000;Nardo et al, 2008) as well as computationally (Kolev et al, 2005;Balasubramanian, 2006;Payton et al, 2007;Galano et al, 2009). In nonpolar solvents, the steadystate absorption spectra of curcumin in cyclohexane (Nardo et al, 2008), toluene , benzene (Khopde et al, 2000), and others (Tønnesen et al, 1995) exhibit a concrete red band or shoulder, which has been ascribed to the diketo tautomer (Khopde et al, 2000;Nardo et al, 2008Nardo et al, , 2009. Curcumin hence adopts both the enol and diketo tautomeric form in nonpolar environments (Balasubramanian, 2006), albeit the diketo tautomer is quantitatively exiguous relative to the enol tautomer (Kolev et al, 2005), and exclusively the enol tautomeric form in solvents with increasing « r (Fig.…”
Section: A Curcumin Structure: Implications On Intermolecular Interamentioning
confidence: 88%
“…The enolic proton and carbonyl oxygen are therefore unavailable for H-bonding to other molecules. The intramolecular H-bonding is perturbed in weakly as well as strongly H-bonding solvents by the polar solvent molecules, as a result of which the enol tautomer adopts an open conformation (Emsley, 1984;Toullec, 1990;Khopde et al, 2000;Nardo et al, 2008), thereby abrogating the symmetry of the semiaromatic ring (Nardo et al, 2008(Nardo et al, , 2009 (Fig. 1B).…”
Section: A Curcumin Structure: Implications On Intermolecular Interamentioning
confidence: 99%
See 2 more Smart Citations
“…Curcumin is a natural compound with diphenolic groups derived from turmeric Curcuma longa, which is widely used in chemotherapy/radiosensitizing of cancer [17][18][19] and other biomedical fields 20,21 with almost no toxicity, 22,23 which has potential as a promising candidate in clinical trials for cancer treatment. However, owing to its poor …”
Section: Introductionmentioning
confidence: 99%